The Moderna company said that a booster dose of its COVID-19 vaccine would be effective against the omicron variant.
A 50-microgram booster dose increases antibody levels 37-fold, and a 100-microgram booster dose increased antibody levels 83-fold compared to levels seen before a booster, according to the company's statement.